SEATTLE, April 3, 2019 /PRNewswire/ -- CTI BioPharma
Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that
management will provide a corporate overview at the 18th
Annual Needham Healthcare Conference at 9:20
a.m. EDT at the Westin New York Grand Central.
Presentation details:
|
Event:
|
18th
Annual Needham Healthcare Conference
|
|
Date:
|
Wednesday, Apr.
10
|
|
Time:
|
9:20 a.m.
EDT
|
The presentation will be webcast live and available for replay
from the Investors section of CTI BioPharma's website at
www.ctibiopharma.com.
About CTI BioPharma Corp.
CTI BioPharma Corp. is
a biopharmaceutical company focused on the acquisition, development
and commercialization of novel targeted therapies covering a
spectrum of blood-related cancers that offer a unique benefit to
patients and healthcare providers. The CTI BioPharma lead product
candidate, pacritinib, is being developed for the treatment of
patients with myelofibrosis. CTI BioPharma is headquartered in
Seattle, Washington.
CTI BioPharma Investor Contacts:
Argot Partners
Maeve Conneighton/Maghan
Meyers
+1-212-600-1902
CTI@argotpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-18th-annual-needham-healthcare-conference-on-wednesday-apr-10-300823558.html
SOURCE CTI BioPharma Corp.